Omalizumab for therapy-resistant chronic urticaria with angioedema

被引：0
|
作者：
Bruch-Gerharz, D. [1 ]
Reifenberger, J. [1 ]
Homey, B. [1 ]
机构：
[1] Univ Dusseldorf, Hautklin, D-40225 Dusseldorf, Germany
来源：
HAUTARZT | 2010年 / 61卷 / 10期
关键词：
Therapy resistant; Chronic urticaria; Angioedema; Combined therapy; Omalizumab; MANAGEMENT; DIAGNOSIS;
D O I：
10.1007/s00105-010-2045-1
中图分类号：
R75 [皮肤病学与性病学];
学科分类号：
100206 ;
摘要：
A 29-old man presented with severe chronic urticaria and angioedema. Routine evaluation including history, laboratory parameters and imaging procedures did not reveal any pathologic findings. We tried combined therapy regimes including high-dose systemic corticosteroids and antihistamines, leukotriene antagonist, cyclosporine and antibiotics. Because of a poor response and dramatic escalation of symptoms, we initiated therapy with omalizumab resulting in the complete remission of the chronic urticaria after two weeks.
引用
收藏
页码：828 / +
页数：3
相关论文
共 50 条
  • [11] Dupilumab combined with Tripterygium wilfordii for a patient with therapy-resistant chronic spontaneous urticaria
    Yang, Ting
    Zou, Ailing
    Zheng, Chen
    [J]. ASIAN JOURNAL OF SURGERY, 2024, 47 (09) : 4169 - 4170
  • [12] IMPACT OF BASELINE ANGIOEDEMA AND IGE ON RESPONSE TO OMALIZUMAB IN CHRONIC SPONTANEOUS URTICARIA
    Casale, T.
    Trzaskoma, B.
    Holden, M.
    Bernstein, J.
    Maurer, M.
    [J]. ANNALS OF ALLERGY ASTHMA & IMMUNOLOGY, 2023, 131 (05) : S35 - S35
  • [13] A critical appraisal of omalizumab as a therapeutic option for chronic refractory urticaria/angioedema
    Lang, David M.
    [J]. ANNALS OF ALLERGY ASTHMA & IMMUNOLOGY, 2014, 112 (04) : 276 - 279
  • [14] Omalizumab treatment in patients with refractory chronic autoimmune urticaria-angioedema
    De Vicente Jimenez, T. M.
    Montoro, A. M.
    Burgos, A.
    Fonseca, J. A.
    Garcia, D.
    Mateos, J. M.
    Nunez, M. A.
    de Mateo, B.
    Fernandez, M.
    [J]. ALLERGY, 2013, 68 : 603 - 603
  • [15] Long term efficacy of Omalizumab for patients with refractory chronic urticaria and angioedema
    Ren, Zhen
    Wedner, H. James
    [J]. JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY, 2018, 141 (02) : AB52 - AB52
  • [16] Angioedema and prescribing of omalizumab for chronic urticaria in countries with limited financial resources
    Popov, Todor A.
    Church, Martin K.
    Christoff, George
    Maurer, Marcus
    [J]. WORLD ALLERGY ORGANIZATION JOURNAL, 2019, 12 (11):
  • [17] Omalizumab in chronic spontaneous urticaria and angioedema; lessons from an Irish cohort
    Sahni, V
    Conlon, N.
    Alias, R.
    Sloane, A.
    Mckeever, A.
    [J]. ALLERGY, 2017, 72 : 718 - 719
  • [18] Does angioedema in patients with chronic spontaneous urticaria impact response to omalizumab?
    Casale, Thomas B.
    Trzaskoma, Benjamin
    Holden, Michael
    Bernstein, Jonathan A.
    Maurer, Marcus
    [J]. WORLD ALLERGY ORGANIZATION JOURNAL, 2024, 17 (08):
  • [19] Successful treatment of chronic idiopathic urticaria & Angioedema (CIU), with Xolair (omalizumab)
    Shapiro, C. A.
    Kapetanos, N. S.
    Sarmiento, E.
    [J]. JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY, 2007, 119 (01) : S274 - S274
  • [20] Advances in allergic skin disease: Omalizumab is a promising therapy for urticaria and angioedema
    Spector, Sheldon L.
    Tan, Ricardo A.
    [J]. JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY, 2009, 123 (01) : 273 - 274
12345